A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT)

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Teal, Philip (BerichterstatterIn) , Hacke, Werner (BerichterstatterIn) , Hennerici, Michael G. (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2009
In: Stroke
Year: 2009, Jahrgang: 40, Heft: 11, Pages: 3518-25
ISSN:1524-4628
DOI:10.1161/STROKEAHA.109.551382
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1161/STROKEAHA.109.551382
Resolving-System, Volltext: http://stroke.ahajournals.org/content/40/11/3518.full.pdf+html
Volltext
Verfasserangaben:Philip Teal ... W. Hacke ...

MARC

LEADER 00000caa a22000002c 4500
001 1487651244
003 DE-627
005 20230426164906.0
007 cr uuu---uuuuu
008 141121s2009 xx |||||o 00| ||eng c
024 7 |a 10.1161/STROKEAHA.109.551382  |2 doi 
035 |a (DE-627)1487651244 
035 |a (DE-576)417651244 
035 |a (DE-599)BSZ417651244 
035 |a (OCoLC)1340654866 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 2 |a A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke  |b modified Randomized Exposure Controlled Trial (mRECT)  |c Philip Teal ... W. Hacke ... 
264 1 |c 2009 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 21.11.2014 
500 |a Advisory board: A. Davalos, Girona, Spain; L. B. Goldstein, Durham, NC; D. F. Hanley, Baltimore, Md; M. Hennerici, Mannheim, Germany; G. L. Lenzi, Rome, Italy; J. M. Orgogozo, Bordeaux, France; R. Sacco, New York, NY 
700 1 |a Teal, Philip  |0 (DE-588)1061198065  |0 (DE-627)805151168  |0 (DE-576)417651139  |4 oth 
700 1 |a Hacke, Werner  |d 1948-  |0 (DE-588)12021699X  |0 (DE-627)080530346  |0 (DE-576)164358854  |4 oth 
700 1 |a Hennerici, Michael G.  |d 1948-  |0 (DE-588)11587545X  |0 (DE-627)077527704  |0 (DE-576)290126444  |4 oth 
773 0 8 |i In  |t Stroke  |d New York, NY : Association, 1970  |g 40(2009), 11, Seite 3518-25  |h Online-Ressource  |w (DE-627)266879985  |w (DE-600)1467823-8  |w (DE-576)075145731  |x 1524-4628  |7 nnas  |a A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke modified Randomized Exposure Controlled Trial (mRECT) 
773 1 8 |g volume:40  |g year:2009  |g number:11  |g pages:3518-25  |g extent:8  |a A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke modified Randomized Exposure Controlled Trial (mRECT) 
856 4 0 |u http://dx.doi.org/10.1161/STROKEAHA.109.551382  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://stroke.ahajournals.org/content/40/11/3518.full.pdf+html  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20141121 
993 |a Article 
994 |a 2009 
998 |g 12021699X  |a Hacke, Werner  |m 12021699X:Hacke, Werner  |d 910000  |d 911100  |e 910000PH12021699X  |e 911100PH12021699X  |k 0/910000/  |k 1/910000/911100/  |p 3 
999 |a KXP-PPN1487651244  |e 2822419574 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"8 S."}],"person":[{"role":"oth","family":"Teal","given":"Philip","display":"Teal, Philip"},{"role":"oth","display":"Hacke, Werner","given":"Werner","family":"Hacke"},{"role":"oth","family":"Hennerici","given":"Michael G.","display":"Hennerici, Michael G."}],"note":["Gesehen am 21.11.2014","Advisory board: A. Davalos, Girona, Spain; L. B. Goldstein, Durham, NC; D. F. Hanley, Baltimore, Md; M. Hennerici, Mannheim, Germany; G. L. Lenzi, Rome, Italy; J. M. Orgogozo, Bordeaux, France; R. Sacco, New York, NY"],"title":[{"subtitle":"modified Randomized Exposure Controlled Trial (mRECT)","title_sort":"randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke","title":"A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke"}],"id":{"eki":["1487651244"],"doi":["10.1161/STROKEAHA.109.551382"]},"origin":[{"dateIssuedDisp":"2009","dateIssuedKey":"2009"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Philip Teal ... W. Hacke ..."]},"relHost":[{"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1970 -"],"disp":"A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke modified Randomized Exposure Controlled Trial (mRECT)Stroke","recId":"266879985","corporate":[{"role":"isb","display":"American Heart Association"}],"part":{"extent":"8","text":"40(2009), 11, Seite 3518-25","pages":"3518-25","issue":"11","volume":"40","year":"2009"},"note":["Gesehen am 29.06.04"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"New York, NY ; Philadelphia, Pa.","publisher":"Association ; Lippincott Williams & Wilkins","dateIssuedKey":"1970","dateIssuedDisp":"1970-"}],"title":[{"subtitle":"journal of the American Heart Association","title_sort":"Stroke","title":"Stroke"}],"id":{"eki":["266879985"],"zdb":["1467823-8"],"issn":["1524-4628"]}}],"language":["eng"],"recId":"1487651244"} 
SRT |a RANDOMIZED2009